Limitations of acetaminophen as a reference hepatotoxin for the evaluation of in vitro liver models
Toxicological Sciences · 2025
DOI: 10.1093/toxsci/kfae133 ↗Kurz gefasst
Fachartikel in der Zeitschrift Toxicological Sciences, 2025. Verfasst von Lucia A Livoti und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology & Therapeutics, Institute of Systems, Molecular & Integrative Biology, University of Liverpool, Liverpool, L69 3GE, United…. Hauptthemen laut MEDLINE: Acetaminophen, Hepatocytes, Chemical and Drug Induced Liver Injury. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council (MRC), Centre for Drug Safety Science, TransQST Consortium.
Abstract (Originalsprache)
Acetaminophen is commonly used as a reference hepatotoxin to demonstrate that in vitro human liver platforms can emulate features of clinical drug-induced liver injury. However, the induction of substantial cell death in these models typically requires acetaminophen concentrations (∼10 mM) far higher than blood concentrations of the drug associated with clinical hepatotoxicity (∼1 mM). Using the cytochrome P450 inhibitor 1-aminobenzotriazole, we show that acetaminophen toxicity in cultured human, mouse, and rat hepatocytes is not dependent on N-acetyl-p-benzoquinonimine formation, unlike the in vivo setting. This finding highlights the limitation of using acetaminophen as a reference hepatotoxin for the evaluation of in vitro liver models. Hence, we make recommendations on the selection of reference hepatotoxins for this purpose.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology & Therapeutics, Institute of Systems, Molecular & Integrative Biology, University of Liverpool, Liverpool, L69 3GE, United Kingdom.
- Certara Predictive Technologies, Sheffield, S1 2BJ, United Kingdom.
- GSK Research and Development Ltd, Stevenage, SG1 2NY, United Kingdom.
- Liverpool University Hospitals NHS Foundation Trust, Liverpool, L7 8YE, United Kingdom.
ORCID-Profile: Dennis Reddyhoff, Ian M Copple
Förderung
- Medical Research Council (MRC)
- Centre for Drug Safety Science
- TransQST Consortium
- Innovative Medicines Initiative 2 Joint Undertaking
- European Union's Horizon 2020 research and innovation program and EFPIA
- European Union's Horizon 2020
- European Union’s Horizon 2020
Zitieren
APA
Livoti, L. A., Sison-Young, R., Reddyhoff, D., Fisher, C. P., Gardner, I., Diaz-Nieto, R., Goldring, C. E., & Copple, I. M. (2025). Limitations of acetaminophen as a reference hepatotoxin for the evaluation of in vitro liver models. Toxicological Sciences. https://doi.org/10.1093/toxsci/kfae133
Vancouver
Livoti LA, Sison-Young R, Reddyhoff D, Fisher CP, Gardner I, Diaz-Nieto R, et al. Limitations of acetaminophen as a reference hepatotoxin for the evaluation of in vitro liver models. Toxicological Sciences. 2025. doi:10.1093/toxsci/kfae133
BibTeX
@article{Livoti2025,
author = {Livoti, Lucia A and Sison-Young, Rowena and Reddyhoff, Dennis and Fisher, Ciarán P and Gardner, Iain and Diaz-Nieto, Rafael and Goldring, Christopher E and Copple, Ian M},
title = {Limitations of acetaminophen as a reference hepatotoxin for the evaluation of in vitro liver models},
journal = {Toxicological Sciences},
year = {2025},
doi = {10.1093/toxsci/kfae133}
}
EUVIMED